C-Path’s Translational Therapeutics Accelerator Announces $473,000 Grant for Drug Development Project in Primary Sclerosing Cholangitis
TUCSON, Ariz, August 19, 2025 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) has awarded a